TriCelX translates science-backed biological solutions to improve aesthetics, orthopedic conditions, and healthy aging. Science drives everything.
Overseen by award-winning orthopedic interventionists, pain management specialists and regenerative medicine practitioners, Orthodynamix offers a portfolio of orthobiological solutions to help people suffering from pain due to aging, injuries, degenerative and inflammatory conditions like arthritis.
Led by renowned cosmetic surgeons, scientists, and aesthetics experts, Luminex is at the vanguard of transformative wellness and beauty, seamlessly blending state-of-the-art cosmetic procedures with our pioneering advancements in cell and biologics-based therapies.
Science is the foundation for what we do. With a portfolio of new age technology, Juvenex’s goal is to bring individualized solutions based upon decades of longevity science to the many, not the few.
Overseen by award-winning orthopedic interventionists, pain management specialists and regenerative medicine practitioners, Orthodynamix offers a portfolio of orthobiological solutions to help people suffering from pain due to aging, injuries, degenerative and inflammatory conditions like arthritis.
Led by renowned cosmetic surgeons, scientists, and aesthetics experts, Luminex is at the vanguard of transformative wellness and beauty, seamlessly blending state-of-the-art cosmetic procedures with our pioneering advancements in cell and biologics-based therapies.
Science is the foundation for what we do. With a portfolio of new age technology, Juvenex’s goal is to bring individualized solutions based upon decades of longevity science to the many, not the few.
Native, non-expanded Mesenchymal Signaling Cells (nMSC), create a robust and holistic healing environment by:
A study to appear in Clinical Neurology and Neurosurgery titled, Traumatic Brain Injury and Stem Cell Treatments: A Review of Recent 10 Years Clinical Trials, concludes:
Stem cell therapy is safe and logistically feasible and leads to neurological improvement in patients with traumatic brain injuries and is perhaps the most promising treatment to this type of injury to date.
To translate the existing science, we are pursuing a dosage study to optimize treatment protocols.
A curated list of research and studies are linked.